Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Metastases × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Osteosarcoma 1 Lung Metastases 1 Humoral Hypercalcemia Of Malignancy 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Bone Metastatic Non-small Cell Lung Cancer 1

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03932071 2019-05-06

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown

Lung Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡